Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria

Pediatr Allergy Immunol. 2015 Sep;26(6):583-5. doi: 10.1111/pai.12413. Epub 2015 Jul 1.

Authors

Stefania Arasi¹, Giuseppe Crisafulli¹, Lucia Caminiti¹, Fabrizio Guarneri², Tommaso Aversa¹, Federica Porcaro¹, Giovanni B Pajno³

Affiliations

¹ Department of Pediatrics- Allergy Unit, University of Messina, Messina, Italy.
² Department of Dermatology, University of Messina, Messina, Italy.
³ Department of Pediatrics- Allergy Unit, University of Messina, Messina, Italy. [email protected].

PMID: 26033828
DOI: 10.1111/pai.12413

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Female
Humans
Immunologic Factors / adverse effects
Immunologic Factors / therapeutic use*
Omalizumab / adverse effects
Omalizumab / therapeutic use*
Photosensitivity Disorders / diagnosis
Photosensitivity Disorders / drug therapy*
Photosensitivity Disorders / etiology
Sunlight / adverse effects*
Treatment Outcome
Urticaria / diagnosis
Urticaria / drug therapy*
Urticaria / etiology

Substances

Immunologic Factors
Omalizumab